Evidence map›Paper›PMID 30128085›Full record

ReviewComputational and structural biotechnology journal2018

Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review.

Bashar Emon, Jessica Bauer, Yasna Jain, Barbara Jung, Taher Saif

Open access · goldAbstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 247 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Bashar EmonMechanical Science and Engineering, University of Illinois at Urbana-Champaign, United States.
Jessica BauerDivision of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, United States.
Yasna JainDepartment of Architecture, BRAC University, Dhaka.
Barbara JungDivision of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, United States.
Taher SaifMechanical Science and Engineering, University of Illinois at Urbana-Champaign, United States.
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · USBRAC University · BD

Funding

Mechanism of colon cancer metastasis: combined role of activin and TGF-beta signalingR01CA141057 · NCI · UNIVERSITY OF WASHINGTON · PI JUNG, BARBARA H · 2010 to 2021
$3.0M
NCI NIH HHS R01 CA141057
6 · The paper itself

Abstract

The role of tumor microenvironment in cancer progression is gaining significant attention. It is realized that cancer cells and the corresponding stroma co-evolve with time. Cancer cells recruit and transform the stromal cells, which in turn remodel the extra cellular matrix of the stroma. This complex interaction between the stroma and the cancer cells results in a dynamic feed-forward/feed-back loop with biochemical and biophysical cues that assist metastatic transition of the cancer cells. Although biochemistry has long been studied for the understanding of cancer progression, biophysical signaling is emerging as a critical paradigm determining cancer metastasis. In this mini review, we discuss the role of one of the biophysical cues, mostly the mechanical stiffness of tumor microenvironment, in cancer progression and its clinical implications.

Indexed as

Activin/TGFβADAMs, AdamalysinsANGPT2, Angiopoietin 2CAF, Cancer associated fibroblastCancerCSF-1, Colony stimulating factor 1CTGF, Connective tissue growth factorCYR61/CCN1, Cysteine-rich angiogenic inducer 61/CCN family member 1ECM, Extracellular matrixECM stiffnessEGF, Epidermal growth factorEMT, Epithelial to mesenchymal transitionFGF, Fibroblast growth factorGrowth factorsHGF/SF, Hepatocyte growth factor/Scatter factorIGFs, Insulin-like growth factorsIL-13, Interleukin-13IL-33, Interleukin-33IL-6, Interleukin-6KGF, Keratinocyte growth factor, also FGF7LOX, Lysyl OxidaseMetastasisMMPs, Matrix metalloproteinasesNO, Nitric oxideSDF-1/CXCL12, Stromal cell-derived factor 1/C-X-C motif chemokine 12TACs, Tumor-associated collagen signaturesTGFβ, Transforming growth factor βTNF-α, Tumor necrosis factor-αTumor biophysicsVEGF, Vascular endothelial growth factorα-SMA, α-Smooth muscle actin

Identifiers

PMID30128085
PMCPMC6097544
OpenAlexW2883081969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.